tallózása szerző szerint "Dias JA"

1-6 / 6

Diagnostic approach and management of cow's milk protein allergy in infants and children

Koletzko S; Niggemann B; Arató, András; Dias JA; Heuschkel R; Husby S; Mearin ML; Papadopoulou A; Ruemmele FM; Staiano A; Schappi MG; Vandenplas Y (2012)

OBJECTIVES:: This position paper provides recommendations for the diagnosis and management of suspected cow's milk protein allergy (CMPA) in Europe. It presents a practical approach with a diagnostic algorithm and is based ...
Diagnostic Workup of Paediatric Patients with Inflammatory Bowel Disease in Europe: Results of a 5-Year Audit of the EUROKIDS Registry

de Bie CI; Buderus S; Sandhu BK; de Ridder L; Paerregaard A; Veres, Gábor; Dias JA; Escher JC; the EUROKIDS Porto IBD Working Group of ESPGHAN (2012)

OBJECTIVE: In 2005, the Inflammatory Bowel Disease (IBD) Working Group of the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition published consensus guidelines on the diagnostic workup of paediatric ...
ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents.

Levine A; Koletzko S; Turner D; Escher JC; Cucchiara S; de Ridder L; Kolho KL; Veres, Gábor; Russell RK; Paerregaard A; Buderus S; Greer ML; Dias JA; Veereman-Wauters G; Lionetti P; Sladek M; Carpi JM; Staiano A; Ruemmele FM; Wilson DC (2014)

BACKGROUND:: The diagnosis of pediatric-onset IBD (PIBD) can be challenging in choosing the most informative diagnostic tests and correctly classifying PIBD into its different subtypes. Recent advances in our understanding ...
Limitations of fecal calprotectin at diagnosis in untreated pediatric Crohn's Disease

Shaoul R; Sladek M; Turner D; Paeregaard A; Veres, Gábor; Wauters GV; Escher J; Dias JA; Lionetti P; Staino A; Kolho KL; de Ridder L; Nuti F; Cucchiara S; Sheva O; Levine A; ESPGHAN Porto IBD Group (2012)

BACKGROUND: Fecal Calprotectin (FC) is a validated screening test for intestinal inflammation in Crohn's disease (CD). The objective of the study was to prospectively evaluate the limitations of FC for identifying CD in ...
Outcome measures for clinical trials in paediatric IBD: an evidence-based, expert-driven practical statement paper of the paediatric ECCO committee.

Ruemmele FM; Hyams JS; Otley A; Griffiths A; Kolho KL; Dias JA; Levine A; Escher JC; Taminiau J; Veres, Gábor; Colombel JF; Vermeire S; Wilson DC; Turner D (2015)

OBJECTIVE: Although paediatric-onset IBD is becoming more common, few medications have a registered paediatric indication. There are multiple hurdles to performing clinical trials in children, emphasising the importance ...
Risk of infection and prevention in pediatric patients with IBD: ESPGHAN IBD Porto group commentary

Veereman-Wauters G; De Ridder L; Veres, Gábor; Kolacek S; Fell J; Malmborg P; Koletzko S; Dias JA; Misak Z; Rahier J-F; Escher JC; ESPGHAN IBD Porto Group (2012)

Combined immunosuppression by immunomodulators and biological therapy has become standard in the medical management of moderate-tosevere inflammatory bowel disease (IBD) because of clearly demonstrated efficacy. Clinical ...

1-6 / 6

Keresés

Összetett keresés

Tallózás

Teljes repozitórumban

Hozzáférésem

Bejelentkezés

tallózása szerző szerint "Dias JA"

DSpace/Manakin Repository

tallózása szerző szerint "Dias JA"

Keresés

Tallózás

Teljes repozitórumban

Hozzáférésem